Market Tracker

06/23 5:16pm ET

Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

3.15
Delayed Data
As of Jun 23
 +0.14 / +4.65%
Today’s Change
1.27
Today|||52-Week Range
7.10
+121.99%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close3.01
Today’s open3.02
Day’s range2.99 - 3.17
Volume236,523
Average volume (3 months)607,385
Market cap$86.7M
Dividend yield--
Data as of 4:02pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+50.00%
Earnings growth (this year)-276.67%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.38

Competitors

 Today’s
change
Today’s
% change
LIFEaTyr Pharma Inc-0.05-1.35%
ARLZAralez Pharmaceutica...-0.01-0.75%
AFMDAffimed NV-0.03-1.20%
MEIPMEI Pharma Inc+0.14+6.48%
Data as of 4:00pm ET, 06/23/2017

Financials

Next reporting dateAugust 16, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$0.00
Annual profit (last year)-$9.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Peter David Suzdak
Chief Financial Officer, Secretary &
Senior VP
Tae Heum Jeong
Corporate headquarters
Rockville, Maryland

Forecasts